1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hemophillia A and B Therapeutics Materials Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Desmopressin 1.2.3 Octocogalfa 1.2.4 Nonacogalfa 1.2.5 Others 1.3 Market by Application 1.3.1 Global Hemophillia A and B Therapeutics Materials Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Dental Clinics 1.3.3 Hospitals 1.3.4 Ambulatory Surgical Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hemophillia A and B Therapeutics Materials Market Perspective (2016-2027) 2.2 Hemophillia A and B Therapeutics Materials Growth Trends by Regions 2.2.1 Hemophillia A and B Therapeutics Materials Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Hemophillia A and B Therapeutics Materials Historic Market Share by Regions (2016-2021) 2.2.3 Hemophillia A and B Therapeutics Materials Forecasted Market Size by Regions (2022-2027) 2.3 Hemophillia A and B Therapeutics Materials Industry Dynamic 2.3.1 Hemophillia A and B Therapeutics Materials Market Trends 2.3.2 Hemophillia A and B Therapeutics Materials Market Drivers 2.3.3 Hemophillia A and B Therapeutics Materials Market Challenges 2.3.4 Hemophillia A and B Therapeutics Materials Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hemophillia A and B Therapeutics Materials Players by Revenue 3.1.1 Global Top Hemophillia A and B Therapeutics Materials Players by Revenue (2016-2021) 3.1.2 Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Players (2016-2021) 3.2 Global Hemophillia A and B Therapeutics Materials Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hemophillia A and B Therapeutics Materials Revenue 3.4 Global Hemophillia A and B Therapeutics Materials Market Concentration Ratio 3.4.1 Global Hemophillia A and B Therapeutics Materials Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hemophillia A and B Therapeutics Materials Revenue in 2020 3.5 Hemophillia A and B Therapeutics Materials Key Players Head office and Area Served 3.6 Key Players Hemophillia A and B Therapeutics Materials Product Solution and Service 3.7 Date of Enter into Hemophillia A and B Therapeutics Materials Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hemophillia A and B Therapeutics Materials Breakdown Data by Type 4.1 Global Hemophillia A and B Therapeutics Materials Historic Market Size by Type (2016-2021) 4.2 Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Type (2022-2027) 5 Hemophillia A and B Therapeutics Materials Breakdown Data by Application 5.1 Global Hemophillia A and B Therapeutics Materials Historic Market Size by Application (2016-2021) 5.2 Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Hemophillia A and B Therapeutics Materials Market Size (2016-2027) 6.2 North America Hemophillia A and B Therapeutics Materials Market Size by Type 6.2.1 North America Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) 6.2.2 North America Hemophillia A and B Therapeutics Materials Market Size by Type (2022-2027) 6.2.3 North America Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2027) 6.3 North America Hemophillia A and B Therapeutics Materials Market Size by Application 6.3.1 North America Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) 6.3.2 North America Hemophillia A and B Therapeutics Materials Market Size by Application (2022-2027) 6.3.3 North America Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2027) 6.4 North America Hemophillia A and B Therapeutics Materials Market Size by Country 6.4.1 North America Hemophillia A and B Therapeutics Materials Market Size by Country (2016-2021) 6.4.2 North America Hemophillia A and B Therapeutics Materials Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Hemophillia A and B Therapeutics Materials Market Size (2016-2027) 7.2 Europe Hemophillia A and B Therapeutics Materials Market Size by Type 7.2.1 Europe Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) 7.2.2 Europe Hemophillia A and B Therapeutics Materials Market Size by Type (2022-2027) 7.2.3 Europe Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2027) 7.3 Europe Hemophillia A and B Therapeutics Materials Market Size by Application 7.3.1 Europe Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) 7.3.2 Europe Hemophillia A and B Therapeutics Materials Market Size by Application (2022-2027) 7.3.3 Europe Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2027) 7.4 Europe Hemophillia A and B Therapeutics Materials Market Size by Country 7.4.1 Europe Hemophillia A and B Therapeutics Materials Market Size by Country (2016-2021) 7.4.2 Europe Hemophillia A and B Therapeutics Materials Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size (2016-2027) 8.2 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Type 8.2.1 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2027) 8.3 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Application 8.3.1 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2027) 8.4 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Region 8.4.1 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hemophillia A and B Therapeutics Materials Market Size (2016-2027) 9.2 Latin America Hemophillia A and B Therapeutics Materials Market Size by Type 9.2.1 Latin America Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) 9.2.2 Latin America Hemophillia A and B Therapeutics Materials Market Size by Type (2022-2027) 9.2.3 Latin America Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2027) 9.3 Latin America Hemophillia A and B Therapeutics Materials Market Size by Application 9.3.1 Latin America Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) 9.3.2 Latin America Hemophillia A and B Therapeutics Materials Market Size by Application (2022-2027) 9.3.3 Latin America Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2027) 9.4 Latin America Hemophillia A and B Therapeutics Materials Market Size by Country 9.4.1 Latin America Hemophillia A and B Therapeutics Materials Market Size by Country (2016-2021) 9.4.2 Latin America Hemophillia A and B Therapeutics Materials Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size (2016-2027) 10.2 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Type 10.2.1 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2027) 10.3 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Application 10.3.1 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2027) 10.4 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Country 10.4.1 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Arsia therapeutics 11.1.1 Arsia therapeutics Company Details 11.1.2 Arsia therapeutics Business Overview 11.1.3 Arsia therapeutics Hemophillia A and B Therapeutics Materials Introduction 11.1.4 Arsia therapeutics Revenue in Hemophillia A and B Therapeutics Materials Business (2016-2021) 11.1.5 Arsia therapeutics Recent Development 11.2 Spark Therapeutics, Inc. 11.2.1 Spark Therapeutics, Inc. Company Details 11.2.2 Spark Therapeutics, Inc. Business Overview 11.2.3 Spark Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Introduction 11.2.4 Spark Therapeutics, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2016-2021) 11.2.5 Spark Therapeutics, Inc. Recent Development 11.3 Alnylam Pharmaceuticals, Inc. 11.3.1 Alnylam Pharmaceuticals, Inc. Company Details 11.3.2 Alnylam Pharmaceuticals, Inc. Business Overview 11.3.3 Alnylam Pharmaceuticals, Inc. Hemophillia A and B Therapeutics Materials Introduction 11.3.4 Alnylam Pharmaceuticals, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2016-2021) 11.3.5 Alnylam Pharmaceuticals, Inc. Recent Development 11.4 Sangamo Therapeutics, Inc. 11.4.1 Sangamo Therapeutics, Inc. Company Details 11.4.2 Sangamo Therapeutics, Inc. Business Overview 11.4.3 Sangamo Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Introduction 11.4.4 Sangamo Therapeutics, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2016-2021) 11.4.5 Sangamo Therapeutics, Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hemophillia A and B Therapeutics Materials Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Desmopressin Table 3. Key Players of Octocogalfa Table 4. Key Players of Nonacogalfa Table 5. Key Players of Others Table 6. Global Hemophillia A and B Therapeutics Materials Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Hemophillia A and B Therapeutics Materials Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Hemophillia A and B Therapeutics Materials Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Hemophillia A and B Therapeutics Materials Market Share by Regions (2016-2021) Table 10. Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Hemophillia A and B Therapeutics Materials Market Share by Regions (2022-2027) Table 12. Hemophillia A and B Therapeutics Materials Market Trends Table 13. Hemophillia A and B Therapeutics Materials Market Drivers Table 14. Hemophillia A and B Therapeutics Materials Market Challenges Table 15. Hemophillia A and B Therapeutics Materials Market Restraints Table 16. Global Hemophillia A and B Therapeutics Materials Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Hemophillia A and B Therapeutics Materials Market Share by Players (2016-2021) Table 18. Global Top Hemophillia A and B Therapeutics Materials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophillia A and B Therapeutics Materials as of 2020) Table 19. Ranking of Global Top Hemophillia A and B Therapeutics Materials Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Hemophillia A and B Therapeutics Materials Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Hemophillia A and B Therapeutics Materials Product Solution and Service Table 23. Date of Enter into Hemophillia A and B Therapeutics Materials Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) (US$ Million) Table 26. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Type (2016-2021) Table 27. Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Hemophillia A and B Therapeutics Materials Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Application (2016-2021) Table 31. Global Hemophillia A and B Therapeutics Materials Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) (US$ Million) Table 34. North America Hemophillia A and B Therapeutics Materials Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) (US$ Million) Table 36. North America Hemophillia A and B Therapeutics Materials Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Hemophillia A and B Therapeutics Materials Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Hemophillia A and B Therapeutics Materials Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Hemophillia A and B Therapeutics Materials Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Hemophillia A and B Therapeutics Materials Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Hemophillia A and B Therapeutics Materials Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Hemophillia A and B Therapeutics Materials Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Hemophillia A and B Therapeutics Materials Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Hemophillia A and B Therapeutics Materials Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Hemophillia A and B Therapeutics Materials Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Hemophillia A and B Therapeutics Materials Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size by Country (2022-2027) & (US$ Million) Table 63. Arsia therapeutics Company Details Table 64. Arsia therapeutics Business Overview Table 65. Arsia therapeutics Hemophillia A and B Therapeutics Materials Product Table 66. Arsia therapeutics Revenue in Hemophillia A and B Therapeutics Materials Business (2016-2021) & (US$ Million) Table 67. Arsia therapeutics Recent Development Table 68. Spark Therapeutics, Inc. Company Details Table 69. Spark Therapeutics, Inc. Business Overview Table 70. Spark Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Product Table 71. Spark Therapeutics, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2016-2021) & (US$ Million) Table 72. Spark Therapeutics, Inc. Recent Development Table 73. Alnylam Pharmaceuticals, Inc. Company Details Table 74. Alnylam Pharmaceuticals, Inc. Business Overview Table 75. Alnylam Pharmaceuticals, Inc. Hemophillia A and B Therapeutics Materials Product Table 76. Alnylam Pharmaceuticals, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2016-2021) & (US$ Million) Table 77. Alnylam Pharmaceuticals, Inc. Recent Development Table 78. Sangamo Therapeutics, Inc. Company Details Table 79. Sangamo Therapeutics, Inc. Business Overview Table 80. Sangamo Therapeutics, Inc. Hemophillia A and B Therapeutics Materials Product Table 81. Sangamo Therapeutics, Inc. Revenue in Hemophillia A and B Therapeutics Materials Business (2016-2021) & (US$ Million) Table 82. Sangamo Therapeutics, Inc. Recent Development Table 83. Research Programs/Design for This Report Table 84. Key Data Information from Secondary Sources Table 85. Key Data Information from Primary Sources List of Figures Figure 1. Global Hemophillia A and B Therapeutics Materials Market Share by Type: 2020 VS 2027 Figure 2. Desmopressin Features Figure 3. Octocogalfa Features Figure 4. Nonacogalfa Features Figure 5. Others Features Figure 6. Global Hemophillia A and B Therapeutics Materials Market Share by Application: 2020 VS 2027 Figure 7. Dental Clinics Case Studies Figure 8. Hospitals Case Studies Figure 9. Ambulatory Surgical Centers Case Studies Figure 10. Hemophillia A and B Therapeutics Materials Report Years Considered Figure 11. Global Hemophillia A and B Therapeutics Materials Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Hemophillia A and B Therapeutics Materials Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Hemophillia A and B Therapeutics Materials Market Share by Regions: 2020 VS 2027 Figure 14. Global Hemophillia A and B Therapeutics Materials Market Share by Regions (2022-2027) Figure 15. Global Hemophillia A and B Therapeutics Materials Market Share by Players in 2020 Figure 16. Global Top Hemophillia A and B Therapeutics Materials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophillia A and B Therapeutics Materials as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Hemophillia A and B Therapeutics Materials Revenue in 2020 Figure 18. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Type (2016-2021) Figure 19. Global Hemophillia A and B Therapeutics Materials Revenue Market Share by Type (2022-2027) Figure 20. North America Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Hemophillia A and B Therapeutics Materials Market Share by Type (2016-2027) Figure 22. North America Hemophillia A and B Therapeutics Materials Market Share by Application (2016-2027) Figure 23. North America Hemophillia A and B Therapeutics Materials Market Share by Country (2016-2027) Figure 24. United States Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Hemophillia A and B Therapeutics Materials Market Share by Type (2016-2027) Figure 28. Europe Hemophillia A and B Therapeutics Materials Market Share by Application (2016-2027) Figure 29. Europe Hemophillia A and B Therapeutics Materials Market Share by Country (2016-2027) Figure 30. Germany Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Share by Type (2016-2027) Figure 38. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Share by Application (2016-2027) Figure 39. Asia-Pacific Hemophillia A and B Therapeutics Materials Market Share by Region (2016-2027) Figure 40. China Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Hemophillia A and B Therapeutics Materials Market Share by Type (2016-2027) Figure 48. Latin America Hemophillia A and B Therapeutics Materials Market Share by Application (2016-2027) Figure 49. Latin America Hemophillia A and B Therapeutics Materials Market Share by Country (2016-2027) Figure 50. Mexico Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Share by Type (2016-2027) Figure 54. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Share by Application (2016-2027) Figure 55. Middle East & Africa Hemophillia A and B Therapeutics Materials Market Share by Country (2016-2027) Figure 56. Turkey Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Hemophillia A and B Therapeutics Materials Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Arsia therapeutics Revenue Growth Rate in Hemophillia A and B Therapeutics Materials Business (2016-2021) Figure 60. Spark Therapeutics, Inc. Revenue Growth Rate in Hemophillia A and B Therapeutics Materials Business (2016-2021) Figure 61. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Hemophillia A and B Therapeutics Materials Business (2016-2021) Figure 62. Sangamo Therapeutics, Inc. Revenue Growth Rate in Hemophillia A and B Therapeutics Materials Business (2016-2021) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

Arsia therapeutics Spark Therapeutics, Inc. Alnylam Pharmaceuticals, Inc. Sangamo Therapeutics, Inc.